AI-developed drug will be in trials by year-end, says Google’s Hassabis
Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...
ReadWrite4d
Trials of drugs developed with AI could begin this year, Google DeepMind CEO says
The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.
Alphabet Inc. (GOOGL)’s Isomorphic Labs to Begin Clinical Trials for AI-Designed Drugs, Targeting Faster Drug Discovery
We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where ...
Wall Street Lunch: AI-Designed Drugs Expected To See Trials This Year
Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.
The Next Web5d
Europe accelerates AI drug discovery as DeepMind spinoff targets trials this year
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...
The Register on MSN5d
Google DeepMind CEO says 2025's the year we start popping pills AI helped invent
Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.
C&EN11d
Q&A: What Novartis’s biomedical research head sees in AI
The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...
DeepMind’s Hassabis Sees AI-Designed Drug Trials This Year
Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...
Google-backed, AI-developed drugs are headed to trial by 2026, DeepMind CEO says
Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.
Yahoo Finance4d
Alphabet Inc. (GOOGL)’s Isomorphic Labs to Begin Clinical Trials for AI-Designed Drugs, Targeting Faster Drug Discovery
We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOGL) stands against the other AI stocks. AI is ...